{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:11:15Z","timestamp":1761059475319},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2013,2,13]],"date-time":"2013-02-13T00:00:00Z","timestamp":1360713600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovasc Intervent Radiol"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1007\/s00270-013-0558-6","type":"journal-article","created":{"date-parts":[[2013,2,12]],"date-time":"2013-02-12T21:55:33Z","timestamp":1360706133000},"page":"1477-1492","source":"Crossref","is-referenced-by-count":15,"title":["Periprocedural Prophylactic Antithrombotic Strategies in Interventional Radiology: Current Practice in the Netherlands and Comparison with the United Kingdom"],"prefix":"10.1007","volume":"36","author":[{"given":"Arno M.","family":"Wiersema","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan-Albert","family":"Vos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelis M. A.","family":"Bruijninckx","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Otto M.","family":"van Delden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel M. P. J.","family":"Reijnen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anco","family":"Vahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clark J.","family":"Zeebregts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frans L.","family":"Moll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,2,13]]},"reference":[{"issue":"1","key":"558_CR1","doi-asserted-by":"crossref","first-page":"204","DOI":"10.2214\/ajr.116.1.204","volume":"116","author":"S Wallace","year":"1972","unstructured":"Wallace S, Medellin H, De Jongh D et al (1972) Systemic heparinization for angiography. Am J Roentgenol Radium Ther Nucl Med 116(1):204\u2013209","journal-title":"Am J Roentgenol Radium Ther Nucl Med"},{"issue":"3","key":"558_CR2","first-page":"573","volume":"111","author":"JH Anderson","year":"1974","unstructured":"Anderson JH, Gianturco C, Wallace S et al (1974) Anticoagulation techniques for angiography. An experimental study. Radiology 111(3):573\u2013576","journal-title":"An experimental study. Radiology"},{"issue":"2","key":"558_CR3","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2214\/ajr.127.2.223","volume":"127","author":"R Antonovic","year":"1976","unstructured":"Antonovic R, Rosch J, Dotter CT (1976) The value of systemic arterial heparinization in transfemoral angiography: A prospective study. AJR Am J Roentgenol 127(2):223\u2013235","journal-title":"AJR Am J Roentgenol"},{"issue":"5","key":"558_CR4","doi-asserted-by":"crossref","first-page":"957","DOI":"10.2214\/ajr.139.5.957","volume":"139","author":"DK Kido","year":"1982","unstructured":"Kido DK, Paulin S, Alenghat JA et al (1982) Thrombogenicity of heparin- and non-heparin-coated catheters: clinical trail. AJR Am J Roentgenol 139(5):957\u2013961","journal-title":"AJR Am J Roentgenol"},{"issue":"5","key":"558_CR5","first-page":"507","volume":"27","author":"KH Lee","year":"2004","unstructured":"Lee KH, Han JK, Byun Y et al (2004) Heparin-coated angiographic catheters: an in vivo comparison of three coating methods with different heparin release profiles. Cardiovasc Intervent Radiol 27(5):507\u2013511","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"6","key":"558_CR6","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1161\/CIRCINTERVENTIONS.110.957381","volume":"3","author":"C Kasapis","year":"2010","unstructured":"Kasapis C, Gurm HS, Chetcuti SJ et al (2010) Defining the optimal degree of heparin anticoagulation for peripheral vascular interventions: insight from a large, regional, multicenter registry. Circ Cardiovasc Interv 3(6):593\u2013601","journal-title":"Circ Cardiovasc Interv"},{"issue":"5","key":"558_CR7","first-page":"242","volume":"15","author":"NW Shammas","year":"2003","unstructured":"Shammas NW, Lemke JH, Dippel EJ et al (2003) In-hospital complications of peripheral vascular interventions using unfractionated heparin as the primary anticoagulant. J Invasive Cardiol 15(5):242\u2013246","journal-title":"J Invasive Cardiol"},{"key":"558_CR8","doi-asserted-by":"crossref","unstructured":"Prechel M, Walenga JM (2012, March 7) Heparin-induced thrombocytopenia: an update. Semin Thromb Hemost [E-pub ahead of print]","DOI":"10.1055\/s-0032-1306432"},{"issue":"9","key":"558_CR9","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.amjcard.2005.06.056","volume":"96","author":"SV Rao","year":"2005","unstructured":"Rao SV, O\u2019Grady K, Pieper KS et al (2005) Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes. Am J Cardiol 96(9):1200\u20131206","journal-title":"Am J Cardiol"},{"issue":"7","key":"558_CR10","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/ccd.21087","volume":"69","author":"L Yatskar","year":"2007","unstructured":"Yatskar L, Selzer F, Feit F et al (2007) Access site hematoma requiring blood transfusion predicts mortality in patients undergoing percutaneous coronary intervention: data from the National Heart, Lung, and Blood Institute Dynamic Registry. Catheter Cardiovasc Interv 69(7):961\u2013966","journal-title":"Catheter Cardiovasc Interv"},{"issue":"3 Pt 2","key":"558_CR11","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1148\/172.3.1007","volume":"172","author":"DL Miller","year":"1989","unstructured":"Miller DL (1989) Heparin in angiography: current patterns of use. Radiology 172(3 Pt 2):1007\u20131011","journal-title":"Radiology"},{"issue":"2","key":"558_CR12","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0009-9260(96)80267-4","volume":"51","author":"SM Zaman","year":"1996","unstructured":"Zaman SM, de Vroos Meiring P, Gandhi MR et al (1996) The pharmacokinetics and UK usage of heparin in vascular intervention. Clin Radiol 51(2):113\u2013116","journal-title":"Clin Radiol"},{"issue":"6","key":"558_CR13","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1007\/s00270-011-0337-1","volume":"35","author":"AC Durran","year":"2012","unstructured":"Durran AC, Watts C (2012) Current trends in heparin use during arterial vascular interventional radiology. Cardiovasc Intervent Radiol 35(6):1308\u20131314","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"2","key":"558_CR14","first-page":"81","volume":"26","author":"L Norgren","year":"2007","unstructured":"Norgren L, Hiatt WR, Dormandy JA et al (2007) Inter-society consensus for the management of peripheral arterial disease. Int Angiol 26(2):81\u2013157","journal-title":"Int Angiol"},{"key":"558_CR15","unstructured":"Cardiovascular and Interventional Radiological Society of Europe (2012) Standards of Practice. Available at: www.cirse.org . Accessed:"},{"issue":"4","key":"558_CR16","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1177\/107424840501000401","volume":"10","author":"JA Bittl","year":"2005","unstructured":"Bittl JA (2005) Bivalirudin vs. heparin in percutaneous coronary intervention: a pooled analysis. J Cardiovasc Pharmacol Ther 10(4):209\u2013216","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"7","key":"558_CR17","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1001\/jama.289.7.853","volume":"289","author":"AM Lincoff","year":"2003","unstructured":"Lincoff AM, Bittl JA, Harrington RA et al (2003) Bivalirudin and provisional glycoprotein IIb\/IIIa blockade compared with heparin and planned glycoprotein IIb\/IIIa blockade during percutaneous coronary intervention: rEPLACE-2 randomized trial. JAMA 289(7):853\u2013863","journal-title":"JAMA"},{"issue":"21","key":"558_CR18","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1056\/NEJMoa062437","volume":"355","author":"GW Stone","year":"2006","unstructured":"Stone GW, McLaurin BT, Cox DA et al (2006) Bivalirudin for patients with acute coronary syndromes. N Engl J Med 355(21):2203\u20132216","journal-title":"N Engl J Med"},{"issue":"9","key":"558_CR19","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.jcin.2009.06.015","volume":"2","author":"IR Sheikh","year":"2009","unstructured":"Sheikh IR, Ahmed SH, Mori N et al (2009) Comparison of safety and efficacy of bivalirudin versus unfractionated heparin in percutaneous peripheral intervention: a single-center experience. JACC Cardiovasc Interv 2(9):871\u2013876","journal-title":"JACC Cardiovasc Interv"},{"issue":"1","key":"558_CR20","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1583\/09-2810.1","volume":"17","author":"NW Shammas","year":"2010","unstructured":"Shammas NW, Shammas GA, Jerin M et al (2010) In-hospital safety and effectiveness of bivalirudin in percutaneous peripheral interventions: data from a real-world registry. J Endovasc Ther 17(1):31\u201336","journal-title":"J Endovasc Ther"},{"issue":"1","key":"558_CR21","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1583\/09-2810C.1","volume":"17","author":"CM Walker","year":"2010","unstructured":"Walker CM (2010) Commentary: bivalirudin is a safe and effective anticoagulant in the percutaneous treatment of complex infrainguinal disease. J Endovasc Ther 17(1):37\u201338","journal-title":"J Endovasc Ther"},{"issue":"1","key":"558_CR22","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jvir.2008.09.031","volume":"20","author":"S Stamler","year":"2009","unstructured":"Stamler S, Katzen BT, Tsoukas AI et al (2009) Clinical experience with the use of bivalirudin in a large population undergoing endovascular abdominal aortic aneurysm repair. J Vasc Interv Radiol 20(1):17\u201321","journal-title":"J Vasc Interv Radiol"},{"issue":"30","key":"558_CR23","first-page":"1670","volume":"149","author":"AC Vahl","year":"2005","unstructured":"Vahl AC, Reekers JA (2005) The guideline \u2018Diagnosis and treatment of peripheral artery disease of the lower extremities\u2019 of The Netherlands Surgical Society. Ned Tijdschr Geneeskd 149(30):1670\u20131674","journal-title":"Ned Tijdschr Geneeskd"},{"key":"558_CR24","first-page":"56","volume":"15","author":"JMG Reijnders","year":"2006","unstructured":"Reijnders JMG, Vahl AC, Reekers JA (2006) Diagnostiek en behandeling van perifeer vaatlijden van de onderste extremiteit. Enquete onder chirurgen en radiologen. Ned Tijdschr Heelkunde 15:56\u201358","journal-title":"Ned Tijdschr Heelkunde"},{"issue":"4","key":"558_CR25","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ejvs.2012.06.008","volume":"44","author":"AM Wiersema","year":"2012","unstructured":"Wiersema AM, Jongkind V, Bruijninckx CM et al (2012) Prophylactic perioperative anti-thrombotics in open and endovascular abdominal aortic aneurysm (AAA) surgery: a systematic review. Eur J Vasc Endovasc Surg 44(4):359\u2013367","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"1","key":"558_CR26","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s00270-010-0004-y","volume":"34","author":"JA Reekers","year":"2011","unstructured":"Reekers JA, Muller-Hulsbeck S, Libicher M et al (2011) CIRSE vascular closure device registry. Cardiovasc Intervent Radiol 34(1):50\u201353","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"6","key":"558_CR27","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.amjcard.2006.10.032","volume":"99","author":"FS Resnic","year":"2007","unstructured":"Resnic FS, Arora N, Matheny M, Reynolds MR (2007) A cost-minimization analysis of the angio-seal vascular closure device following percutaneous coronary intervention. Am J Cardiol 99(6):766\u2013770","journal-title":"Am J Cardiol"},{"issue":"17","key":"558_CR28","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.jacc.2007.07.028","volume":"50","author":"HL Dauermann","year":"2007","unstructured":"Dauermann HL, Applegate RJ, Cohen DJ (2007) Vascular closure devices: the second decade. J Am Coll Cardiol 50(17):1617\u20131626","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"558_CR29","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejcts.2008.02.024","volume":"34","author":"J Dunning","year":"2008","unstructured":"Dunning J, Versteegh M, Fabbri A et al (2008) Guideline on antiplatelet and anticoagulation management in cardiac surgery. Eur J Cardiothorac Surg 34(1):73\u201392 for the EACTS Audit and Guidelines Committee","journal-title":"Eur J Cardiothorac Surg"},{"issue":"5","key":"558_CR30","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.ahj.2007.12.014","volume":"155","author":"PJ Castarella","year":"2008","unstructured":"Castarella PJ, Tcheng JE (2008) Review of the 2005 American College of Cardiology, American Heart Association, and Society for Cardiovascular interventions guidelines for adjunctive pharmacologic therapy during percutaneous coronary interventions: practical implications, new clinical data, and recommended guideline revisions. Am Heart J 155(5):781\u2013790","journal-title":"Am Heart J"},{"issue":"5","key":"558_CR31","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1161\/CIRCINTERVENTIONS.111.961912","volume":"4","author":"S Bangalore","year":"2011","unstructured":"Bangalore S, Cohen DJ, Kleiman NS et al (2011) Bleeding risk comparing targeted low-dose heparin with bivalirudin in patients undergoing percutaneous coronary intervention: results from a propensity score-matched analysis of the Evaluation of Drug-Eluting Stents and Ischemic Events (EVENT) registry. Circ Cardiovasc Interv 4(5):463\u2013473 for the EVENT Registry Investigators","journal-title":"Circ Cardiovasc Interv"},{"key":"558_CR32","unstructured":"Lupi A, Rognoni A, Cavalinno C, et al. (2012, September 5) Pharmacological adjuvant therapies in primary coronary interventions: bivalirudin. Cardiovasc Hematol Agents Med Chem [Epub ahead of print]"},{"issue":"4","key":"558_CR33","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.amjcard.2012.03.051","volume":"110","author":"OF Betrand","year":"2012","unstructured":"Betrand OF, Jolly SS, Rao SV et al (2012) Meta-analysis comparing bivalirudin versus heparin monotherapy on ischemic and bleeding outcomes after percutaneous coronary intervention. Am J Cardiol 110(4):599\u2013606","journal-title":"Am J Cardiol"}],"container-title":["CardioVascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-013-0558-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00270-013-0558-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-013-0558-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T17:11:57Z","timestamp":1562692317000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00270-013-0558-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,13]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["558"],"URL":"https:\/\/doi.org\/10.1007\/s00270-013-0558-6","relation":{},"ISSN":["0174-1551","1432-086X"],"issn-type":[{"value":"0174-1551","type":"print"},{"value":"1432-086X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,13]]}}}